Invention Grant
- Patent Title: Quinolines and azaquinolines as inhibitors of CD38
-
Application No.: US17586939Application Date: 2022-01-28
-
Publication No.: US11952377B2Publication Date: 2024-04-09
- Inventor: Jennifer Downing , Kevin Wayne Kuntz , Laurie B. Schenkel , Melissa Marie Vasbinder
- Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- Applicant Address: DE Ingelheim
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim
- Agency: Fish & Richardson P.C.
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D401/04 ; C07D401/14 ; C07D405/14
Abstract:
The present invention relates to bicyclic heterocycle compounds of Formula (I):
and pharmaceutically acceptable salts thereof, which are inhibitors of CD38 and are useful in the treatment of cancer.
and pharmaceutically acceptable salts thereof, which are inhibitors of CD38 and are useful in the treatment of cancer.
Public/Granted literature
- US20220242862A1 QUINOLINES AND AZAQUINOLINES AS INHIBITORS OF CD38 Public/Granted day:2022-08-04
Information query
